Speaker illustration

Doctor Stefanie Aeschbacher

University Hospital Basel, Basel (Switzerland)

Serum light-chain neurofilament is associated with brain atrophy in patients with atrial fibrillation

Event: ESC Congress 2019

Topic: Prevention

Session: Atrial fibrillation pathophysiology and mechanisms

Thumbnail

Atrial fibrillation related symptoms and cardiovascular outcomes

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmia general prevention and diagnosis

Thumbnail

Relationship between aldosterone-to-renin ratio and blood pressure in young adults from the general population

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session: Hypertension Pathophysiology and Risk

Thumbnail

Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Stroke prevention

Thumbnail

Relationship between structural brain damage and cognitive function in patients with atrial fibrillation

Event: ESC Congress 2018

Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation

Session: Atrial fibrillation: epidemiology, prognosis, outcome 2

Thumbnail

Symptoms and Health Perception in Atrial Fibrillation Patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Registries and cost of treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb